References
- Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O ‘Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42. doi:https://doi.org/10.1161/111.068064. PMID:22379110.
- Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension. 2011;57(6):1076–80. doi:https://doi.org/10.1161/HYPERTENSIONAHA.111.170308.
- Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlöf B, Poulter NR. ASCOT Investigators. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens. 2011;29(10):2004–13. doi:https://doi.org/10.1097/HJH.0b013e32834a8a42.
- Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;19(11):2063–70.doi:https://doi.org/10.1097/00004872-200111000-00018.
- Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002 May;117(2):399–404. doi:https://doi.org/10.1046/j.1365-2141.2002.03441.x.
- Thompson CB, Eaton K, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol. 1982;50(3):509–19. doi:https://doi.org/10.1111/j.1365-2141.1982.tb01947.x.
- Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–26. doi:https://doi.org/10.1056/NEJM199901143400207.
- Wang R, Li Y, Zhu X, Zhang Y. Increased mean platelet volume is associated with arterial stiffness. Platelets. 2011 Sep;22(6):447–51. doi:https://doi.org/10.3109/09537104.2011.565431.
- Navarro-Soriano C, Martínez-García M, Torres G, Barbé F, Caballero-Eraso C, Lloberes P, Cambriles TD, Somoza M, Masa JF, González M, et al. Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study. Hypertens Res. 2019 Nov;42(11):1708–15. doi:https://doi.org/10.1038/s41440-019-0285-8.
- Narita K, Hoshide S, Kario K. Association of treatment -resistant hypertension defined by home blood pressure monitoring with cardiovascular outcomes. Hypertens Res. 2021 Oct 17; doi:https://doi.org/10.1038/s41440-021-00757-4. published Online ahead of print.
- Kario K, Hoshide S, Narita K, Okawara Y, Kanegae H, Aoki K, Kihara H, Koga T, Nakata T, Oku K. JAMP investogators’ network.Cardiovascular prognosis in drug-resistant hypertension stratified by 24-hour ambulatory blood pressure: the JAMP study. Hypertension. 2021 Nov 1;78(6):1781–90. doi:https://doi.org/10.1161/HYPERTENSIONAHA.121.18198. published Online ahead of print.
- Chiu N, Lauffenburger JC, Franklin JM, Choudhry NK. Prevalence, predictors, and outcomes of both true- and pseudo- resistant hypertension in the action to control cardiovascular risk in diabetes trial: a cohort study. Hypertens Res. 2021;44(11):1471–82. doi:https://doi.org/10.1038/s41440-021-00739-6.
- Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk. J Thromb Haemost. 2010;8(1):146–47. doi:https://doi.org/10.1111/j.1538-7836.2009.03673.x.
- Barradas MA, Mikhailidis DP. Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease. Braz J Med Biol Res. 1992;25(11):1063–76.
- Barradas MA, O’Donoghue S, Mikhailidis DP. Measurement of platelet volume using a channelyzer: assessment of the effect of agonists and antaagonists. In Vivo (Brooklyn). 1992;6(6):629–34.
- Papanas N, Mikhailidis DP. Mean platelet volume: a predictor of mortality in diabetic and nondiabetic patients with STEMI. J Diabetes Complications. 2014;28(5):581–82. doi:https://doi.org/10.1016/j.jdiacomp.2014.05.004.
- Archontogeorgis K, Voulgaris A, Papanas N, Nena E, Froudarakis M, Mikhailidis DP, Steiropoulos, p, Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease. Clin Appl Thromb Hemost. 2018 Nov;24(8):1216–22.
- Nena E, Papanas N, Steiropoulos P, Zikidou P, Zarogoulidis P, Pita E, Constantinidis, TC, Maltezos, E, Mihailidis, DP, Burosu, D, Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with Obstructive Sleep Apnoea Syndrome: new indices of severity. Platelets. 2012 Sep;23(6):447–54. doi:https://doi.org/10.3109/09537104.2011.632031.
- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation. Curr Pharm Des. 2011;17(1):47–58. doi:https://doi.org/10.2174/138161211795049804.
- Ntolios P, Papanas N, Nena E, Boglou P, Koulelidis A, Tzouvelekis A, Xanthoudaki, M, Tsigalou, C, Froudarakis, ME, Bouros, D, Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis. Clin Appl Thromb Hemost. 2016 May;22(4):346–50.
- Papanas N, Mikhailidis DP, Steiropoulos P. Obstructive sleep apnea and cardiovascular disease: is mean platelet volume one of the links. Anatol J Cardiol. 2016;16(3):223. doi:https://doi.org/10.14744/AnatolJCardiol.2016.6902.
- Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–88. doi:https://doi.org/10.1182/blood-2014-08-531582.
- Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123(18):2759–67. doi:https://doi.org/10.1182/blood-2013-11-462432.
- Targoński R, Sadowski J, Price S, Targoński R. Sodium-induced inflammation—an invisible player in resistant hypertension. Hypertens Res. 2020 Jul;43(7):629–33. doi:https://doi.org/10.1038/s41440-020-0428-y.
- Gang L, Yanyan Z, Zhongwei Z, Juan D. Association between mean platelet volume and hypertension incidence. Hypertens Res. 2017 Aug;40(8):779–84. doi:https://doi.org/10.1038/hr.2017.30.
- Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004;44(2):415–22. doi:https://doi.org/10.1016/j.jacc.2004.03.067.
- Giles C, Inglis TC. Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol. 1981;88(11):1115–19. doi:https://doi.org/10.1111/j.1471-0528.1981.tb01764.x.
- Coban E, Yazıcıoglu G, Avcı AB, Akcıt F. The mean platelet volume in patients with essential and white coat hypertension. Platelets. 2005;16(7):435–38. doi:https://doi.org/10.1080/09537100500163572.
- Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res. 2007;120(2):245–50. doi:https://doi.org/10.1016/j.thromres.2006.10.005.